Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph A Tripp

Showing results (51-60 of 238) with videos related to

Pageof 24
Sort By:
Frontiers in Immunology|January 6, 2025
Editorial: How RSV outsmarts the hostStephania A Cormier, Lawrence M Kauvar, Ralph A Tripp
The Journal of Infectious Diseases|November 6, 2004
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxisJennifer L Harcourt, Ruth A Karron, Ralph A Tripp
Scientific Reports|September 29, 2021
Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replicationCynthia Mathew, Sharon Tamir, Ralph A Tripp, et al.
Frontiers in Microbiology|February 9, 2026
Intersection of inflammation and viral replication: the central role of MAPK signaling in viral respiratory infectionsRalph A Tripp, Les P Jones, David E Martin
Expert Review of Respiratory Medicine|August 23, 2013
Advances in and the potential of vaccines for respiratory syncytial virusPatricia A Jorquera, Katie E Oakley, Ralph A Tripp
Microorganisms|September 28, 2023
Interferons-Implications in the Immune Response to Respiratory VirusesHarrison C Bergeron, Matthew R Hansen, Ralph A Tripp
Current Issues in Molecular Biology|July 23, 2025
The MAPK Response to Virus Infection Is Modified by ProbenecidLes P Jones, David E Martin, Ralph A Tripp
Scientific Reports|October 6, 2017
MicroRNA-134 regulates poliovirus replication by IRES targetingAbhijeet A Bakre, Byoung-Shik Shim, Ralph A Tripp
Therapeutic Advances in Infectious Disease|March 20, 2023
Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon responseHarrison C Bergeron, Lawrence M Kauvar, Ralph A Tripp
Frontiers in Pharmacology|May 15, 2026
Probenecid is a dual-acting antiviral/anti-inflammatory therapy for diverse respiratory virusesRalph A Tripp, Les P Jones, David E Martin
Pageof 24

Showing results (51-60 of 238) with videos related to

Sort By:
Pageof 24
Frontiers in Immunology|January 6, 2025
Editorial: How RSV outsmarts the hostStephania A Cormier, Lawrence M Kauvar, Ralph A Tripp
The Journal of Infectious Diseases|November 6, 2004
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxisJennifer L Harcourt, Ruth A Karron, Ralph A Tripp
Scientific Reports|September 29, 2021
Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replicationCynthia Mathew, Sharon Tamir, Ralph A Tripp, et al.
Frontiers in Microbiology|February 9, 2026
Intersection of inflammation and viral replication: the central role of MAPK signaling in viral respiratory infectionsRalph A Tripp, Les P Jones, David E Martin
Expert Review of Respiratory Medicine|August 23, 2013
Advances in and the potential of vaccines for respiratory syncytial virusPatricia A Jorquera, Katie E Oakley, Ralph A Tripp
Microorganisms|September 28, 2023
Interferons-Implications in the Immune Response to Respiratory VirusesHarrison C Bergeron, Matthew R Hansen, Ralph A Tripp
Current Issues in Molecular Biology|July 23, 2025
The MAPK Response to Virus Infection Is Modified by ProbenecidLes P Jones, David E Martin, Ralph A Tripp
Scientific Reports|October 6, 2017
MicroRNA-134 regulates poliovirus replication by IRES targetingAbhijeet A Bakre, Byoung-Shik Shim, Ralph A Tripp
Therapeutic Advances in Infectious Disease|March 20, 2023
Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon responseHarrison C Bergeron, Lawrence M Kauvar, Ralph A Tripp
Frontiers in Pharmacology|May 15, 2026
Probenecid is a dual-acting antiviral/anti-inflammatory therapy for diverse respiratory virusesRalph A Tripp, Les P Jones, David E Martin
Pageof 24